144 related articles for article (PubMed ID: 38732035)
1. Unveiling the Genomic Landscape of Intraductal Carcinoma of the Prostate Using Spatial Gene Expression Analysis.
Watanabe R; Miura N; Kurata M; Kitazawa R; Kikugawa T; Saika T
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732035
[TBL] [Abstract][Full Text] [Related]
2. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded.
Samaratunga H; Delahunt B; Egevad L; Srigley JR; Billis A; Bostwick DG; Camparo P; Cheng L; Clouston D; Denham J; Furusato B; Hartmann A; Jufe L; Kench J; Kenwright DN; Kristiansen G; Leite KRM; MacLennan GT; Merrimen J; Moch H; Oxley J; Pan CC; Paner G; Ro J; Sesterhenn IAM; Shanks J; Thunders M; Tsuzuki T; Wheeler T; Yaxley JW; Varma M
Pathology; 2020 Feb; 52(2):192-196. PubMed ID: 31843189
[TBL] [Abstract][Full Text] [Related]
3. Isolated Intraductal Carcinoma of the Prostate in Prostatectomy Specimens: Report of 2 Cases and Review of the Literature.
Grypari IM; Logotheti S; Lazaris AC; Kallidonis P; Fokaefs E; Melachrinou M; Zolota V; Tzelepi V
Int J Surg Pathol; 2020 Dec; 28(8):918-924. PubMed ID: 32456482
[TBL] [Abstract][Full Text] [Related]
4. Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic Parameter.
Samaratunga H; Delahunt B; Yaxley JW; Johannsen S; Egevad L
Am J Surg Pathol; 2021 Nov; 45(11):1527-1533. PubMed ID: 34265803
[TBL] [Abstract][Full Text] [Related]
5. Intraductal carcinoma of the prostate in the ejaculatory duct.
Sanchez-Salazar AJ; Basler JW; Nicolas MM
Int J Surg Pathol; 2010 Aug; 18(4):298-9. PubMed ID: 20444733
[TBL] [Abstract][Full Text] [Related]
6. Intraductal carcinoma of the prostate: a critical re-appraisal.
Varma M; Delahunt B; Egevad L; Samaratunga H; Kristiansen G
Virchows Arch; 2019 May; 474(5):525-534. PubMed ID: 30825003
[TBL] [Abstract][Full Text] [Related]
7. Intraductal Carcinoma of the Prostate: A Guide for the Practicing Pathologist.
Varma M
Adv Anat Pathol; 2021 Jul; 28(4):276-287. PubMed ID: 33990497
[TBL] [Abstract][Full Text] [Related]
8. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications.
Henry PC; Evans AJ
J Clin Pathol; 2009 Jul; 62(7):579-83. PubMed ID: 19246509
[TBL] [Abstract][Full Text] [Related]
9. Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.
Sorvina A; Martini C; Prabhakaran S; Logan JM; S-Y Ung B; Moore C; Johnson IRD; Lazniewska J; Tewari P; Malone V; Brooks RD; Hickey SM; Caruso MC; Klebe S; Karageorgos L; O'Leary JJ; Delahunt B; Samaratunga H; Brooks DA
Pathology; 2023 Oct; 55(6):792-799. PubMed ID: 37422404
[TBL] [Abstract][Full Text] [Related]
10. Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies.
Chen-Maxwell D; Prendeville S
Histopathology; 2020 Sep; 77(3):503-507. PubMed ID: 32358793
[TBL] [Abstract][Full Text] [Related]
11. Independence of HIF1a and androgen signaling pathways in prostate cancer.
Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
[TBL] [Abstract][Full Text] [Related]
12. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
[TBL] [Abstract][Full Text] [Related]
13. Grade group 4 prostate cancer without intraductal carcinoma on biopsy is more likely to be downgraded on prostatectomy than with intraductal carcinoma.
Trabzonlu L; Chaiprasit T; Kontosis A; Picken M
Virchows Arch; 2024 Mar; 484(3):517-520. PubMed ID: 38267757
[TBL] [Abstract][Full Text] [Related]
14. [The Value of MRI Texture Analysis in Identifying Intraductal Carcinoma of the Prostate Gland].
Chu L; Si Y; Liu RB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):42-48. PubMed ID: 31950788
[TBL] [Abstract][Full Text] [Related]
15. Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer.
Watanabe R; Miura N; Kurata M; Kitazawa R; Kikugawa T; Saika T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240308
[TBL] [Abstract][Full Text] [Related]
16. Head to head: should the intraductal component of invasive prostate cancer be graded?
Varma M; Epstein JI
Histopathology; 2021 Jan; 78(2):231-239. PubMed ID: 32692448
[TBL] [Abstract][Full Text] [Related]
17. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
[TBL] [Abstract][Full Text] [Related]
18. Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Taylor RA; Fraser M; Livingstone J; Espiritu SM; Thorne H; Huang V; Lo W; Shiah YJ; Yamaguchi TN; Sliwinski A; Horsburgh S; Meng A; Heisler LE; Yu N; Yousif F; Papargiris M; Lawrence MG; Timms L; Murphy DG; Frydenberg M; Hopkins JF; Bolton D; Clouston D; McPherson JD; van der Kwast T; Boutros PC; Risbridger GP; Bristow RG
Nat Commun; 2017 Jan; 8():13671. PubMed ID: 28067867
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prostatic adenocarcinoma Gleason 5 and intraductal carcinoma of the prostate with tumor necrosis. A morphometric study.
Acosta AM; Vormittag E; Al Rasheed MRH; Sharif A; Mon KS; Kajdacsy-Balla A; Mohapatra G
Pathol Res Pract; 2018 Oct; 214(10):1681-1685. PubMed ID: 30195638
[TBL] [Abstract][Full Text] [Related]
20. Biologically different subgroups of invasive ductal carcinoma of the pancreas: Dpc4 status according to the ratio of intraductal carcinoma components.
Takahashi H; Oda T; Hasebe T; Aoyagi Y; Kinoshita T; Konishi M; Nakagohri T; Inoue K; Takahashi S; Kawahira H; Monden M; Ochiai A
Clin Cancer Res; 2004 Jun; 10(11):3772-9. PubMed ID: 15173084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]